AGP Picks
View all

Today in Healthcare: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Healthcare.

Press releases published on July 2, 2026

American Center for Psychiatry and Neurology Earns Certified Autism Center™ Designation
As Australian Frontier Tech Funding Hits Records, CoLabs Brings Sydney the Lab Infrastructure to Match
CoLabs Australia Secures $397,074 to Help DeepTech Founders Build What the Market Actually Wants
Tradeshift Recognized among Top Accounts Payable Invoice Automation Software Vendors in Independent Analyst Evaluation
Cosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market Purchases
Cell and Gene Therapy Clinical Trials Market Size to Reach US$44.2 Billion by 2033 at a CAGR of 16.4%
Vaccine to Treat ‘Neglected Disease’ Shows Promising Results
Elena Aesthetics & Wellness in Great Neck, Bringing Advanced PicoWay® Laser and Glacē™ Skin Treatments to Long Island
Needle-Free Injectors Market Size to Reach US$ 245.5 Million by 2033 at 9.7% CAGR | Persistence Market Research
CBDrmd.com Launches CBD Gummies and CBD Oil Transparency Initiative
Trial Validates First Treatment to Actually Improve Alzheimer’s Disease
My Book of Hope Shares an Inspiring Journey From Depression to Healing and Renewal
GENFIT annonce l’accès à la couverture et le futur remboursement par Medicare aux États-Unis de NASHnext®, une technologie visant à identifier les patients atteints de MASH « à risque »
GENFIT Announces U.S. Medicare Coverage and Future Reimbursement for NASHnext®, a Non-Invasive Diagnostic Technology to Identify Patients with At-Risk MASH
Profusa Announces 1-for-25 Reverse Stock Split
SRX Global Makes Strategic Investment in Critical and Precious Minerals Development Company, Greenland Mines
Codex Labs to Present Pediatric Eczema Study Showing 95% SCORAD Reduction Without Steroids at SPD 2026 Annual Meeting
MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals
New Large-Scale Meta-Analysis Demonstrates Strong Prognostic Performance of Myriad’s Prolaris® Biopsy Test in Localized Prostate Cancer
Qolab Announces $54.2 Million Series B Financing and Commitments Led by UC Investments to Accelerate the Future of Quantum Computing

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today in Healthcare

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.